Viewing StudyNCT00300274



Ignite Creation Date: 2024-05-05 @ 4:43 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00300274
Status: COMPLETED
Last Update Posted: 2012-08-16
First Post: 2006-03-06

Brief Title: Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Organization Data

Organization: Novartis
Class: INDUSTRY
Study ID: CRAD001A2310
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novartis Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators